Lilly?s Neuroscience Research Chief Resigns

David Bredt's last day at the drug maker is Feb. 25, a company spokeswoman says. He had joined Lilly in 2004.

Source: http://feedproxy.google.com/~r/wsj/health/feed/~3/QyV_umWh9wg/

athletes health migraines teeth